grampian multiple sclerosis therapy centre limited
grampian multiple sclerosis therapy centre limited Company Information
Company Number
SC126417
Next Accounts
Sep 2025
Industry
Other social work activities without accommodation n.e.c.
Shareholders
-
Group Structure
View All
Contact
Registered Address
amicable house, 252 union street, aberdeen, AB10 1TN
Website
www.grampianms.orggrampian multiple sclerosis therapy centre limited Estimated Valuation
Pomanda estimates the enterprise value of GRAMPIAN MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED at £76.8k based on a Turnover of £158.9k and 0.48x industry multiple (adjusted for size and gross margin).
grampian multiple sclerosis therapy centre limited Estimated Valuation
Pomanda estimates the enterprise value of GRAMPIAN MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED at £94.9k based on an EBITDA of £24.4k and a 3.9x industry multiple (adjusted for size and gross margin).
grampian multiple sclerosis therapy centre limited Estimated Valuation
Pomanda estimates the enterprise value of GRAMPIAN MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED at £899.2k based on Net Assets of £299.1k and 3.01x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Grampian Multiple Sclerosis Therapy Centre Limited Overview
Grampian Multiple Sclerosis Therapy Centre Limited is a live company located in aberdeen, AB10 1TN with a Companies House number of SC126417. It operates in the other social work activities without accommodation n.e.c. sector, SIC Code 88990. Founded in July 1990, it's largest shareholder is unknown. Grampian Multiple Sclerosis Therapy Centre Limited is a mature, micro sized company, Pomanda has estimated its turnover at £158.9k with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Grampian Multiple Sclerosis Therapy Centre Limited Health Check
Pomanda's financial health check has awarded Grampian Multiple Sclerosis Therapy Centre Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 2 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
2 Weak
Size
annual sales of £158.9k, make it smaller than the average company (£451.6k)
£158.9k - Grampian Multiple Sclerosis Therapy Centre Limited
£451.6k - Industry AVG
Growth
3 year (CAGR) sales growth of 21%, show it is growing at a faster rate (6%)
21% - Grampian Multiple Sclerosis Therapy Centre Limited
6% - Industry AVG
Production
with a gross margin of 47.9%, this company has a comparable cost of product (47.9%)
47.9% - Grampian Multiple Sclerosis Therapy Centre Limited
47.9% - Industry AVG
Profitability
an operating margin of 15% make it more profitable than the average company (3.9%)
15% - Grampian Multiple Sclerosis Therapy Centre Limited
3.9% - Industry AVG
Employees
with 3 employees, this is below the industry average (12)
3 - Grampian Multiple Sclerosis Therapy Centre Limited
12 - Industry AVG
Pay Structure
on an average salary of £28k, the company has an equivalent pay structure (£25.1k)
£28k - Grampian Multiple Sclerosis Therapy Centre Limited
£25.1k - Industry AVG
Efficiency
resulting in sales per employee of £53k, this is more efficient (£43.1k)
£53k - Grampian Multiple Sclerosis Therapy Centre Limited
£43.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Grampian Multiple Sclerosis Therapy Centre Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 16 days, this is slower than average (4 days)
16 days - Grampian Multiple Sclerosis Therapy Centre Limited
4 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Grampian Multiple Sclerosis Therapy Centre Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 2835 weeks, this is more cash available to meet short term requirements (253 weeks)
2835 weeks - Grampian Multiple Sclerosis Therapy Centre Limited
253 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.8%, this is a lower level of debt than the average (10.8%)
1.8% - Grampian Multiple Sclerosis Therapy Centre Limited
10.8% - Industry AVG
GRAMPIAN MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED financials
Grampian Multiple Sclerosis Therapy Centre Limited's latest turnover from December 2023 is £158.9 thousand and the company has net assets of £299.1 thousand. According to their latest financial statements, Grampian Multiple Sclerosis Therapy Centre Limited has 3 employees and maintains cash reserves of £303.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 158,871 | 128,328 | 175,870 | 89,905 | 125,546 | 109,151 | 129,606 | 77,605 | 91,846 | 77,744 | 195,174 | 81,885 | 95,184 | 76,879 | 85,636 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 160 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 29,210 | 8,753 | 64,249 | -19,817 | 35,193 | 7,603 | 35,250 | -16,725 | 3,735 | -8,535 | 104,174 | -4,685 | 4,702 | -9,213 | 6,067 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 29,210 | 8,753 | 64,249 | -19,817 | 35,193 | 7,603 | 35,250 | -16,725 | 3,735 | -8,535 | 104,174 | -4,685 | 4,702 | -9,213 | 6,067 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 29,210 | 8,753 | 64,249 | -19,817 | 35,193 | 7,603 | 35,250 | -16,725 | 3,735 | -8,535 | 104,174 | -4,685 | 4,702 | -9,213 | 6,067 |
| Employee Costs | 83,993 | 79,501 | 72,527 | 75,344 | 58,233 | 57,553 | 55,869 | 54,189 | 53,799 | 52,591 | 52,893 | 53,285 | 51,918 | 50,417 | 47,744 |
| Number Of Employees | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 3 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,270 | 1,835 | 1,980 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 1,270 | 1,835 | 1,980 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 404 | 319 | 35,706 | 4,797 | 27,418 | 410 | 431 | 430 | 0 | 0 | 0 | 0 | 0 |
| Cash | 303,417 | 274,131 | 265,269 | 200,062 | 185,633 | 181,482 | 151,203 | 142,635 | 159,195 | 155,820 | 165,422 | 58,777 | 63,452 | 59,471 | 68,779 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 381 | 0 | 0 | 0 | 0 |
| total current assets | 303,417 | 274,131 | 265,673 | 200,381 | 221,339 | 186,279 | 178,621 | 143,045 | 159,626 | 156,250 | 165,803 | 58,777 | 63,452 | 59,471 | 68,779 |
| total assets | 304,687 | 275,966 | 267,653 | 200,381 | 221,339 | 186,279 | 178,621 | 143,045 | 159,626 | 156,250 | 165,803 | 58,777 | 63,452 | 59,471 | 68,779 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 3,801 | 3,016 | 3,623 | 174 | 194 | 84 | 2,137 | 2,153 | 468 | 802 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 1,764 | 3,038 | 2,871 | 3,297 | 4,418 | 4,661 | 2,553 | 2,211 | 3,752 | 3,777 | 5,596 | 2,744 | 2,734 | 3,455 | 3,550 |
| total current liabilities | 5,565 | 6,054 | 6,494 | 3,471 | 4,612 | 4,745 | 4,690 | 4,364 | 4,220 | 4,579 | 5,596 | 2,744 | 2,734 | 3,455 | 3,550 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 5,565 | 6,054 | 6,494 | 3,471 | 4,612 | 4,745 | 4,690 | 4,364 | 4,220 | 4,579 | 5,596 | 2,744 | 2,734 | 3,455 | 3,550 |
| net assets | 299,122 | 269,912 | 261,159 | 196,910 | 216,727 | 181,534 | 173,931 | 138,681 | 155,406 | 151,671 | 160,207 | 56,033 | 60,718 | 56,016 | 65,229 |
| total shareholders funds | 299,122 | 269,912 | 261,159 | 196,910 | 216,727 | 181,534 | 173,931 | 138,681 | 155,406 | 151,671 | 160,207 | 56,033 | 60,718 | 56,016 | 65,229 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 565 | 505 | 396 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | -404 | 85 | -35,387 | 30,909 | -22,621 | 27,008 | -21 | 1 | 430 | 0 | 0 | 0 | 0 | 0 |
| Creditors | 785 | -607 | 3,449 | -20 | 110 | -2,053 | -16 | 1,685 | -334 | 802 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | -1,274 | 167 | -426 | -1,121 | -243 | 2,108 | 342 | -1,541 | -25 | -1,819 | 2,852 | 10 | -721 | -95 | 3,550 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | -160 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from financing | 0 | 0 | 0 | 0 | 0 | -160 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 59,162 |
| cash and cash equivalents | |||||||||||||||
| cash | 29,286 | 8,862 | 65,207 | 14,429 | 4,151 | 30,279 | 8,568 | -16,560 | 3,375 | -9,602 | 106,645 | -4,675 | 3,981 | -9,308 | 68,779 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 29,286 | 8,862 | 65,207 | 14,429 | 4,151 | 30,279 | 8,568 | -16,560 | 3,375 | -9,602 | 106,645 | -4,675 | 3,981 | -9,308 | 68,779 |
grampian multiple sclerosis therapy centre limited Credit Report and Business Information
Grampian Multiple Sclerosis Therapy Centre Limited Competitor Analysis
Perform a competitor analysis for grampian multiple sclerosis therapy centre limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in AB10 area or any other competitors across 12 key performance metrics.
grampian multiple sclerosis therapy centre limited Ownership
GRAMPIAN MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED group structure
Grampian Multiple Sclerosis Therapy Centre Limited has no subsidiary companies.
Ultimate parent company
GRAMPIAN MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED
SC126417
grampian multiple sclerosis therapy centre limited directors
Grampian Multiple Sclerosis Therapy Centre Limited currently has 2 directors. The longest serving directors include Mr James Craig (Jan 2010) and Mr James McLean (Jun 2016).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr James Craig | United Kingdom | 79 years | Jan 2010 | - | Director |
| Mr James McLean | Scotland | 67 years | Jun 2016 | - | Director |
P&L
December 2023turnover
158.9k
+24%
operating profit
23.8k
0%
gross margin
47.9%
+2.02%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
299.1k
+0.11%
total assets
304.7k
+0.1%
cash
303.4k
+0.11%
net assets
Total assets minus all liabilities
grampian multiple sclerosis therapy centre limited company details
company number
SC126417
Type
Private Ltd By Guarantee w/o Share Cap
industry
88990 - Other social work activities without accommodation n.e.c.
incorporation date
July 1990
age
34
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
grampian friends of arms limited (September 2008)
accountant
BARRIE ALEXANDER
auditor
-
address
amicable house, 252 union street, aberdeen, AB10 1TN
Bank
BANK OF SCOTLAND
Legal Advisor
-
grampian multiple sclerosis therapy centre limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to grampian multiple sclerosis therapy centre limited.
grampian multiple sclerosis therapy centre limited Companies House Filings - See Documents
| date | description | view/download |
|---|
